Terms: = Ovarian cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
76 results:
1. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
2. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
3. Somatic Genomic and Transcriptomic Characterization of Primary ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas.
Stružinská I; Hájková N; Hojný J; Krkavcová E; Michálková R; Bui QH; Matěj R; Laco J; Drozenová J; Fabian P; Škapa P; Špůrková Z; Cibula D; Frühauf F; Jirásek T; Zima T; Méhes G; Kendall Bártů M; Němejcová K; Dundr P
J Mol Diagn; 2024 Apr; 26(4):257-266. PubMed ID: 38280423
[TBL] [Abstract] [Full Text] [Related]
4. Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Heublein S; Pfisterer J; du Bois A; Anglesio M; Aminossadati B; Bhatti I; Sehouli J; Wimberger P; Schochter F; Hilpert F; Hillemanns P; Kalder M; Schroeder W; Mahner S; Burges A; Canzler U; Gropp-Meier M; Jackisch C; Harter P; Kommoss S; Marmé F
Lab Invest; 2024 Apr; 104(4):100321. PubMed ID: 38154497
[TBL] [Abstract] [Full Text] [Related]
5. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent fgfr2 and CTNNB1 mutations: a case report.
Xu J; Park KJ; Rehrauer WM; Weisman PS
Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
[TBL] [Abstract] [Full Text] [Related]
6. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Mueller SH; Lai AG; Valkovskaya M; Michailidou K; Bolla MK; Wang Q; Dennis J; Lush M; Abu-Ful Z; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Baert T; Freeman LEB; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Brenner H; Brucker SY; Buys SS; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Choi JY; Chung WK; ; Colonna SV; ; Cornelissen S; Couch FJ; Czene K; Daly MB; Devilee P; Dörk T; Dossus L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Engel C; Evans DG; Fasching PA; Fletcher O; Flyger H; Gago-Dominguez M; Gao YT; García-Closas M; García-Sáenz JA; Genkinger J; Gentry-Maharaj A; Grassmann F; Guénel P; Gündert M; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hall P; Harkness EF; Harrington PA; Hartikainen JM; Hartman M; Hein A; Ho WK; Hooning MJ; Hoppe R; Hopper JL; Houlston RS; Howell A; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakubowska A; Janni W; John EM; Jones ME; Jung A; Kaaks R; Kang D; Khusnutdinova EK; Kim SW; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Kwong A; Lacey JV; Lambrechts D; Le Marchand L; Li J; Linet M; Lo WY; Long J; Lophatananon A; Mannermaa A; Manoochehri M; Margolin S; Matsuo K; Mavroudis D; Menon U; Muir K; Murphy RA; Nevanlinna H; Newman WG; Niederacher D; O'Brien KM; Obi N; Offit K; Olopade OI; Olshan AF; Olsson H; Park SK; Patel AV; Patel A; Perou CM; Peto J; Pharoah PDP; Plaseska-Karanfilska D; Presneau N; Rack B; Radice P; Ramachandran D; Rashid MU; Rennert G; Romero A; Ruddy KJ; Ruebner M; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneider MO; Scott C; Shah M; Sharma P; Shen CY; Shu XO; Simard J; Surowy H; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Toland AE; Tollenaar RAEM; Torres D; Torres-Mejía G; Troester MA; Truong T; Vachon CM; Vijai J; Weinberg CR; Wendt C; Winqvist R; Wolk A; Wu AH; Yamaji T; Yang XR; Yu JC; Zheng W; Ziogas A; Ziv E; Dunning AM; Easton DF; Hemingway H; Hamann U; Kuchenbaecker KB
Genome Med; 2023 Jan; 15(1):7. PubMed ID: 36703164
[TBL] [Abstract] [Full Text] [Related]
7. Spatial expression of the fgfr2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma.
Sengal AT; Smith D; Snell CE; Leung S; Talhouk A; Williams ED; McAlpine JN; Pollock PM
J Pathol Clin Res; 2022 Nov; 8(6):521-537. PubMed ID: 35866380
[TBL] [Abstract] [Full Text] [Related]
8. Endometrial, ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
Halling GC; Udager AM; Skala SL
Int J Gynecol Pathol; 2023 May; 42(3):247-253. PubMed ID: 35639393
[TBL] [Abstract] [Full Text] [Related]
9. Mucinous Tumor Coexisting With Mesonephric-like Proliferation/Tumor in the Ovary: A Novel Association.
Nilforoushan N; Liu L; Cheang G; Sui AC; Andersen J; Finkelman BS; Liu Y; Nasseri-Nik N; Vang R; Ronnett BM; Song W; Xing D
Am J Surg Pathol; 2022 Aug; 46(8):1095-1105. PubMed ID: 35405716
[TBL] [Abstract] [Full Text] [Related]
10. MassArray analysis of genomic susceptibility variants in ovarian cancer.
Verma S; Sharma I; Sharma V; Bhat A; Shah R; Bhat GR; Sharma B; Bakshi D; Nagpal A; Wakhloo A; Bhat A; Kumar R
Sci Rep; 2020 Dec; 10(1):21101. PubMed ID: 33273524
[TBL] [Abstract] [Full Text] [Related]
11. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
[TBL] [Abstract] [Full Text] [Related]
12. A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors.
Wang B; Tang Q; Xu L; Teng X; Ding W; Ren G; Wang X
Mod Pathol; 2021 Jan; 34(1):42-50. PubMed ID: 32732929
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Profiles of Mixed Endometrial Carcinoma.
Matrai C; Motanagh S; Mirabelli S; Ma L; He B; Chapman-Davis E; Kurtis B; Elemento O; Mosquera JM; Ellenson LH
Am J Surg Pathol; 2020 Aug; 44(8):1104-1111. PubMed ID: 32604171
[TBL] [Abstract] [Full Text] [Related]
14. Co-expressed functional module-related genes in ovarian cancer stem cells represent novel prognostic biomarkers in ovarian cancer.
Gov E
Syst Biol Reprod Med; 2020 Aug; 66(4):255-266. PubMed ID: 32441533
[TBL] [Abstract] [Full Text] [Related]
15. Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation.
Skala SL; Liu CJ; Udager AM; Sciallis AP
Mod Pathol; 2020 Oct; 33(10):1989-2000. PubMed ID: 32404953
[TBL] [Abstract] [Full Text] [Related]
16. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
Russo M; Newell JM; Budurlean L; Houser KR; Sheldon K; Kesterson J; Phaeton R; Hossler C; Rosenberg J; DeGraff D; Shuman L; Broach JR; Warrick JI
Cancer; 2020 Jun; 126(12):2775-2783. PubMed ID: 32187665
[TBL] [Abstract] [Full Text] [Related]
17. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract] [Full Text] [Related]
18. New Gene Markers of Angiogenesis and Blood Vessels Development in Porcine ovarian Granulosa Cells during Short-Term Primary Culture In Vitro.
Chermuła B; Brązert M; Iżycki D; Ciesiółka S; Kranc W; Celichowski P; Ożegowska K; Nawrocki MJ; Jankowski M; Jeseta M; Antosik P; Bukowska D; Skowroński MT; Brussow KP; Bruska M; Pawelczyk L; Zabel M; Nowicki M; Kempisty B
Biomed Res Int; 2019; 2019():6545210. PubMed ID: 30834271
[TBL] [Abstract] [Full Text] [Related]
19. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
20. Acquired JHDM1D-BRAF Fusion Confers Resistance to FGFR Inhibition in
Sase H; Nakanishi Y; Aida S; Horiguchi-Takei K; Akiyama N; Fujii T; Sakata K; Mio T; Aoki M; Ishii N
Mol Cancer Ther; 2018 Oct; 17(10):2217-2225. PubMed ID: 30045926
[No Abstract] [Full Text] [Related]
[Next]
